BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 14560032)

  • 1. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
    Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
    Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
    Nies AT; Herrmann E; Brom M; Keppler D
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
    Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
    J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.
    Jonker JW; Wagenaar E; Mol CA; Buitelaar M; Koepsell H; Smit JW; Schinkel AH
    Mol Cell Biol; 2001 Aug; 21(16):5471-7. PubMed ID: 11463829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
    Choi MK; Song IS
    Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters.
    Meyer MJ; Falk S; Römer S; Prinzinger C; Tacke S; Geyer J; Simm S; Tzvetkov MV
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
    Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
    Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2.
    Suo Y; Wright NJ; Guterres H; Fedor JG; Butay KJ; Borgnia MJ; Im W; Lee SY
    Nat Struct Mol Biol; 2023 Jul; 30(7):1001-1011. PubMed ID: 37291422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency.
    Schömig E; Lazar A; Gründemann D
    Handb Exp Pharmacol; 2006; (175):151-80. PubMed ID: 16722235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
    Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule.
    Kaewmokul S; Chatsudthipong V; Evans KK; Dantzler WH; Wright SH
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1149-59. PubMed ID: 12944320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
    Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
    Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes.
    Okuda M; Urakami Y; Saito H; Inui K
    Biochim Biophys Acta; 1999 Mar; 1417(2):224-31. PubMed ID: 10082798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
    Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.
    Mayati A; Bruyere A; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
    PLoS One; 2015; 10(12):e0144667. PubMed ID: 26657401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
    Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
    Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
    Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
    Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.